Global Bioprocess Technology
Global Bioprocess Technology

Bioprocess Technology Comprehensive Study by Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, Virus Infiltration), Application (Specialty Products, Biopharmaceuticals, Environment Management, Industrial Chemicals), End User (Research Labs, Medical Institutions, Hospitals, Others) Players and Region - Global Market Outlook to 2024

Bioprocess Technology Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 201 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Bioprocess Technology Market Overview:
A bioprocess is any process which uses complete living cells or their components for example bacteria, enzymes, chloroplast to obtain desired products. This process is commonly known to as Fermentation. Bioprocess technology deals with the design and development of equipment and procedures for the manufacturing of products. Meanwhile, bioprocesses uses living material, they deliver numerous benefits over conventional chemical methods of production including it typically need minor temperature, pressure, and pH; it uses renewable resources as raw materials and larger quantities can be produced with less energy consumption. Some of the key players profiled in the study are Philips Healthcare (Netherlands), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Becton, Dickinson and Company (United States), GE Healthcare (United States), Merck Millipore (Germany), Danaher Corporation (United States), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France) and Charles River Laboratories (United States).

On the basis of geography, the market of Bioprocess Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Research Labs will boost the Bioprocess Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • High Growth in Biopharmaceutical Industry
  • Increase in R&D Expenditure in Developed Countries
  • Rise in Number of New Drug Launches

Market Trend
  • Growing Demand for Vaccines
  • Increasing Prevalence of HIV and Cancer

Restraints
  • Strict Regulatory Policies

Opportunities
  • Potential Growth Offered by Emerging Markets
  • Growing Pharmaceutical Outsourcing

Challenges
  • Need of High Capital Investments to Set Up New Production Facilities
  • Difficulties in Reagent Development


On May 20, 2019 - Merck has announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. It will provide vaccine process development training courses within TRANSVAC2, a collaborative infrastructure project under Horizon 2020.

Under the authority of the Food, Drug, and Cosmetic Act of 1938, the U.S. Food and Drug Administration (FDA) evaluates and regulates the safety of biotechnology-derived products in the same way that it does for conventionally manufactured products. Scientific, safety, and regulatory issues are considered prior to approval for commercial production. Once a product receives approval, enforcement of the laws and regulations at the manufacturing level is accomplished by FDA's field personnel. The individual firm's manufacturing and quality control procedures are reviewed and evaluated to determine if they are in compliance with the Current Good Manufacturing Practice regulations.

Target Audience:
Academic Research Institutions, Pharmaceutical Industry, Biotechnology Industry, Bioprocess Technology Manufacturing Companies, Research Organizations and Governmental Bodies

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Bioprocess Technology market on the basis of product [Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry and Virus Infiltration] , application [Specialty Products, Biopharmaceuticals, Environment Management and Industrial Chemicals], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Bioprocess Technology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Bioprocess Technology industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Corning, Inc. (United States) and Bio-Rad Laboratories (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Bioprocess Technology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Cell Expansion
  • Cell Culture
  • Cell Line Development
  • Flow Cytometry
  • Virus Infiltration
By Application
  • Specialty Products
  • Biopharmaceuticals
  • Environment Management
  • Industrial Chemicals
By End User
  • Research Labs
  • Medical Institutions
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Growth in Biopharmaceutical Industry
      • 3.2.2. Increase in R&D Expenditure in Developed Countries
      • 3.2.3. Rise in Number of New Drug Launches
    • 3.3. Market Challenges
      • 3.3.1. Need of High Capital Investments to Set Up New Production Facilities
      • 3.3.2. Difficulties in Reagent Development
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Vaccines
      • 3.4.2. Increasing Prevalence of HIV and Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bioprocess Technology, by Type, Application, End User and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Bioprocess Technology (Value)
      • 5.2.1. Global Bioprocess Technology by: Type (Value)
        • 5.2.1.1. Cell Expansion
        • 5.2.1.2. Cell Culture
        • 5.2.1.3. Cell Line Development
        • 5.2.1.4. Flow Cytometry
        • 5.2.1.5. Virus Infiltration
      • 5.2.2. Global Bioprocess Technology by: Application (Value)
        • 5.2.2.1. Specialty Products
        • 5.2.2.2. Biopharmaceuticals
        • 5.2.2.3. Environment Management
        • 5.2.2.4. Industrial Chemicals
      • 5.2.3. Global Bioprocess Technology by: End User (Value)
        • 5.2.3.1. Research Labs
        • 5.2.3.2. Medical Institutions
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Others
      • 5.2.4. Global Bioprocess Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Bioprocess Technology (Price)
      • 5.3.1. Global Bioprocess Technology by: Type (Price)
  • 6. Bioprocess Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Philips Healthcare (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GE Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck Millipore (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lonza Group AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sartorius Stedim Biotech S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Charles River Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bioprocess Technology Sale, by Type, Application, End User and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Bioprocess Technology (Value)
      • 7.2.1. Global Bioprocess Technology by: Type (Value)
        • 7.2.1.1. Cell Expansion
        • 7.2.1.2. Cell Culture
        • 7.2.1.3. Cell Line Development
        • 7.2.1.4. Flow Cytometry
        • 7.2.1.5. Virus Infiltration
      • 7.2.2. Global Bioprocess Technology by: Application (Value)
        • 7.2.2.1. Specialty Products
        • 7.2.2.2. Biopharmaceuticals
        • 7.2.2.3. Environment Management
        • 7.2.2.4. Industrial Chemicals
      • 7.2.3. Global Bioprocess Technology by: End User (Value)
        • 7.2.3.1. Research Labs
        • 7.2.3.2. Medical Institutions
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Others
      • 7.2.4. Global Bioprocess Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Bioprocess Technology (Price)
      • 7.3.1. Global Bioprocess Technology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bioprocess Technology: by Type(USD Million)
  • Table 2. Bioprocess Technology Cell Expansion , by Region USD Million (2013-2018)
  • Table 3. Bioprocess Technology Cell Culture , by Region USD Million (2013-2018)
  • Table 4. Bioprocess Technology Cell Line Development , by Region USD Million (2013-2018)
  • Table 5. Bioprocess Technology Flow Cytometry , by Region USD Million (2013-2018)
  • Table 6. Bioprocess Technology Virus Infiltration , by Region USD Million (2013-2018)
  • Table 7. Bioprocess Technology: by Application(USD Million)
  • Table 8. Bioprocess Technology Specialty Products , by Region USD Million (2013-2018)
  • Table 9. Bioprocess Technology Biopharmaceuticals , by Region USD Million (2013-2018)
  • Table 10. Bioprocess Technology Environment Management , by Region USD Million (2013-2018)
  • Table 11. Bioprocess Technology Industrial Chemicals , by Region USD Million (2013-2018)
  • Table 12. Bioprocess Technology: by End User(USD Million)
  • Table 13. Bioprocess Technology Research Labs , by Region USD Million (2013-2018)
  • Table 14. Bioprocess Technology Medical Institutions , by Region USD Million (2013-2018)
  • Table 15. Bioprocess Technology Hospitals , by Region USD Million (2013-2018)
  • Table 16. Bioprocess Technology Others , by Region USD Million (2013-2018)
  • Table 17. South America Bioprocess Technology, by Country USD Million (2013-2018)
  • Table 18. South America Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 19. South America Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 20. South America Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 21. Brazil Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 22. Brazil Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 23. Brazil Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 24. Argentina Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 25. Argentina Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 26. Argentina Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 27. Rest of South America Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 28. Rest of South America Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 29. Rest of South America Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 30. Asia Pacific Bioprocess Technology, by Country USD Million (2013-2018)
  • Table 31. Asia Pacific Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 32. Asia Pacific Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 33. Asia Pacific Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 34. China Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 35. China Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 36. China Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 37. Japan Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 38. Japan Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 39. Japan Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 40. India Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 41. India Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 42. India Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 43. South Korea Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 44. South Korea Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 45. South Korea Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 46. Taiwan Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 47. Taiwan Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 48. Taiwan Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 49. Australia Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 50. Australia Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 51. Australia Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 55. Europe Bioprocess Technology, by Country USD Million (2013-2018)
  • Table 56. Europe Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 57. Europe Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 58. Europe Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 59. Germany Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 60. Germany Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 61. Germany Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 62. France Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 63. France Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 64. France Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 65. Italy Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 66. Italy Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 67. Italy Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 68. United Kingdom Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 69. United Kingdom Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 70. United Kingdom Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 71. Netherlands Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 72. Netherlands Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 73. Netherlands Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 74. Rest of Europe Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 75. Rest of Europe Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 76. Rest of Europe Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 77. MEA Bioprocess Technology, by Country USD Million (2013-2018)
  • Table 78. MEA Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 79. MEA Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 80. MEA Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 81. Middle East Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 82. Middle East Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 83. Middle East Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 84. Africa Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 85. Africa Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 86. Africa Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 87. North America Bioprocess Technology, by Country USD Million (2013-2018)
  • Table 88. North America Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 89. North America Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 90. North America Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 91. United States Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 92. United States Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 93. United States Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 94. Canada Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 95. Canada Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 96. Canada Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 97. Mexico Bioprocess Technology, by Type USD Million (2013-2018)
  • Table 98. Mexico Bioprocess Technology, by Application USD Million (2013-2018)
  • Table 99. Mexico Bioprocess Technology, by End User USD Million (2013-2018)
  • Table 100. Bioprocess Technology: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Bioprocess Technology: by Type(USD Million)
  • Table 112. Bioprocess Technology Cell Expansion , by Region USD Million (2019-2024)
  • Table 113. Bioprocess Technology Cell Culture , by Region USD Million (2019-2024)
  • Table 114. Bioprocess Technology Cell Line Development , by Region USD Million (2019-2024)
  • Table 115. Bioprocess Technology Flow Cytometry , by Region USD Million (2019-2024)
  • Table 116. Bioprocess Technology Virus Infiltration , by Region USD Million (2019-2024)
  • Table 117. Bioprocess Technology: by Application(USD Million)
  • Table 118. Bioprocess Technology Specialty Products , by Region USD Million (2019-2024)
  • Table 119. Bioprocess Technology Biopharmaceuticals , by Region USD Million (2019-2024)
  • Table 120. Bioprocess Technology Environment Management , by Region USD Million (2019-2024)
  • Table 121. Bioprocess Technology Industrial Chemicals , by Region USD Million (2019-2024)
  • Table 122. Bioprocess Technology: by End User(USD Million)
  • Table 123. Bioprocess Technology Research Labs , by Region USD Million (2019-2024)
  • Table 124. Bioprocess Technology Medical Institutions , by Region USD Million (2019-2024)
  • Table 125. Bioprocess Technology Hospitals , by Region USD Million (2019-2024)
  • Table 126. Bioprocess Technology Others , by Region USD Million (2019-2024)
  • Table 127. South America Bioprocess Technology, by Country USD Million (2019-2024)
  • Table 128. South America Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 129. South America Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 130. South America Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 131. Brazil Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 132. Brazil Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 133. Brazil Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 134. Argentina Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 135. Argentina Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 136. Argentina Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 137. Rest of South America Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 138. Rest of South America Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 139. Rest of South America Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 140. Asia Pacific Bioprocess Technology, by Country USD Million (2019-2024)
  • Table 141. Asia Pacific Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 142. Asia Pacific Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 143. Asia Pacific Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 144. China Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 145. China Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 146. China Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 147. Japan Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 148. Japan Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 149. Japan Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 150. India Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 151. India Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 152. India Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 153. South Korea Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 154. South Korea Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 155. South Korea Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 156. Taiwan Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 157. Taiwan Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 158. Taiwan Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 159. Australia Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 160. Australia Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 161. Australia Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 162. Rest of Asia-Pacific Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 164. Rest of Asia-Pacific Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 165. Europe Bioprocess Technology, by Country USD Million (2019-2024)
  • Table 166. Europe Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 167. Europe Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 168. Europe Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 169. Germany Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 170. Germany Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 171. Germany Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 172. France Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 173. France Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 174. France Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 175. Italy Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 176. Italy Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 177. Italy Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 178. United Kingdom Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 179. United Kingdom Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 180. United Kingdom Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 181. Netherlands Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 182. Netherlands Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 183. Netherlands Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 184. Rest of Europe Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 185. Rest of Europe Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 186. Rest of Europe Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 187. MEA Bioprocess Technology, by Country USD Million (2019-2024)
  • Table 188. MEA Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 189. MEA Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 190. MEA Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 191. Middle East Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 192. Middle East Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 193. Middle East Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 194. Africa Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 195. Africa Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 196. Africa Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 197. North America Bioprocess Technology, by Country USD Million (2019-2024)
  • Table 198. North America Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 199. North America Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 200. North America Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 201. United States Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 202. United States Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 203. United States Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 204. Canada Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 205. Canada Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 206. Canada Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 207. Mexico Bioprocess Technology, by Type USD Million (2019-2024)
  • Table 208. Mexico Bioprocess Technology, by Application USD Million (2019-2024)
  • Table 209. Mexico Bioprocess Technology, by End User USD Million (2019-2024)
  • Table 210. Bioprocess Technology: by Type(USD/Units)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bioprocess Technology: by Type USD Million (2013-2018)
  • Figure 5. Global Bioprocess Technology: by Application USD Million (2013-2018)
  • Figure 6. Global Bioprocess Technology: by End User USD Million (2013-2018)
  • Figure 7. South America Bioprocess Technology Share (%), by Country
  • Figure 8. Asia Pacific Bioprocess Technology Share (%), by Country
  • Figure 9. Europe Bioprocess Technology Share (%), by Country
  • Figure 10. MEA Bioprocess Technology Share (%), by Country
  • Figure 11. North America Bioprocess Technology Share (%), by Country
  • Figure 12. Global Bioprocess Technology: by Type USD/Units (2013-2018)
  • Figure 13. Global Bioprocess Technology share by Players 2018 (%)
  • Figure 14. Global Bioprocess Technology share by Players (Top 3) 2018(%)
  • Figure 15. Global Bioprocess Technology share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 18. Philips Healthcare (Netherlands) Revenue: by Geography 2018
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2018
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 25. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 26. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 27. Merck Millipore (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Merck Millipore (Germany) Revenue: by Geography 2018
  • Figure 29. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 31. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Lonza Group AG (Switzerland) Revenue: by Geography 2018
  • Figure 33. Sartorius Stedim Biotech S.A (France) Revenue, Net Income and Gross profit
  • Figure 34. Sartorius Stedim Biotech S.A (France) Revenue: by Geography 2018
  • Figure 35. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. Charles River Laboratories (United States) Revenue: by Geography 2018
  • Figure 37. Global Bioprocess Technology: by Type USD Million (2019-2024)
  • Figure 38. Global Bioprocess Technology: by Application USD Million (2019-2024)
  • Figure 39. Global Bioprocess Technology: by End User USD Million (2019-2024)
  • Figure 40. South America Bioprocess Technology Share (%), by Country
  • Figure 41. Asia Pacific Bioprocess Technology Share (%), by Country
  • Figure 42. Europe Bioprocess Technology Share (%), by Country
  • Figure 43. MEA Bioprocess Technology Share (%), by Country
  • Figure 44. North America Bioprocess Technology Share (%), by Country
  • Figure 45. Global Bioprocess Technology: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Philips Healthcare (Netherlands)
  • Abbott Laboratories (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • GE Healthcare (United States)
  • Merck Millipore (Germany)
  • Danaher Corporation (United States)
  • Lonza Group AG (Switzerland)
  • Sartorius Stedim Biotech S.A (France)
  • Charles River Laboratories (United States)
Additional players considered in the study are as follows:
Corning, Inc. (United States) , Bio-Rad Laboratories (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation